Management of Diabetes During a Dual Pandemic
| Autor: | Theresa M. Wadas, Mudasir S. Andrabi, Susan J. Appel |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) Health care provider 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Intensive care Diabetes mellitus Pandemic medicine Advanced and Specialised Nursing 030212 general & internal medicine Intensive care medicine Advanced and Specialized Nursing diabetes Continuous glucose monitoring business.industry Mortality rate COVID-19 Featured Article medicine.disease Additional research new-onset diabetes mellitus insulin therapy coronavirus disease 2019 (COVID-19) continuous glucose monitoring business |
| Zdroj: | The Journal for Nurse Practitioners |
| ISSN: | 1878-058X 1555-4155 |
| Popis: | The dual pandemics of coronavirus disease-19 (COVID-19) and diabetes among patients are associated with 2- to 3-times higher intensive care admissions and higher mortality rates. Whether sheltering at home, quarantined with a positive COVID-19 test, or hospitalized, the person living with diabetes needs special considerations for successful management. Having diabetes and being COVID-19–positive increases the risk of poor outcomes and death. Providers need to give anticipatory pharmacologic guidance to patients with diabetes during COVID-19 lockdown. Patients with diabetes need to be more observant than others and to use self-protective actions. This review (1) discusses the clinical observations of COVID-19, diabetes and underlying mechanisms, (2) describes special considerations in caring for patients with diabetes in a COVID-19 environment, and (3) reviews clinical implications for the health care provider. This review highlights current evidenced-based knowledge. Additional research regarding clinical management is warranted |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect